Envoy biosciences
Envoy biosciences are developing next generation vaccines and probiotics to help protect poultry from Avian Pathogenic E. coli (APEC)-related diseases (colibacillosis).
WHO WE ARE
About Envoy Biosciences
Envoy biosciences are developing an innovative manufacturing platform for producing bacterial vesicles that can be used as vaccines, therapeutics and probiotics. We are focusing on developing next generation vaccines and probiotics that are designed to protect poultry, including chickens, from E. coli infections. The purpose of our landing page is to explore interest in the market for poultry E. coli vaccines but also to gauge interest in our bacterial vesicle manufacturing platform more generally across pharma/biotech.
Prevention of E. coli infections through vaccination is a safe and cost-effective way to improve flock welfare. Indeed, poultry APEC vaccines can reduce mortality by over 35%, help prevent APEC-related productivity declines in egg and meat production whilst also reducing antibiotic use.
THE PROBLEM
The Challenge Facing Poultry Health
Widespread Threat to Poultry
Avian Pathogenic E. coli (APEC) is a major cause of infectious diseases in poultry – including chickens, turkeys, and ducks – posing a serious and ongoing health challenge across the globe.
Global Prevalence
APEC is found in poultry populations worldwide, making it a universal concern for farmers, producers, and veterinarians in every major poultry-producing region.
Massive Economic Impact
Colibacillosis, the group of diseases caused by APEC, costs the global poultry industry hundreds of millions of dollars every year through productivity losses, bird culling, and meat condemnation.
Productivity and Food Waste
Infected birds often must be culled, and their meat discarded, contributing not only to economic loss but also to food waste and supply chain inefficiencies.
OUR SOLUTION
Powerful Protection
Less Antibiotics
Envoy Biosciences is pioneering next-generation bacterial vesicle-based vaccines and probiotics to outsmart APEC. Our cutting-edge approach offers broader, safer, and more effective protection than conventional E. coli vaccines – improving poultry health and producer outcomes.
Better Productivity, Less Loss
Vaccination can reduce mortality by over 35% and prevent productivity drops – leading to up to 20% more eggs, heavier birds, and higher meat yields.
Broader Cross-Protection
Our vesicle-based vaccines target a wider range of APEC strains than existing live vaccines, helping protect flocks against more threats with a single solution.
Reduced Antibiotic Use
By preventing infections before they start, our solutions help lower dependence on antibiotics – supporting regulatory compliance and antimicrobial stewardship.
Safe & Cost-Effective Prevention
Vaccination is a proactive, scalable, and economical approach to poultry health – delivering long-term value and peace of mind for producers.
Share Your Expertise. Shape The Future.
We’re building better APEC solutions and your input matters. Take a quick survey to guide our work.
MEET THE TEAM
Explore the Expertise of Our Team
Supported By
GET IN TOUCH
Let’s start the conversation
Whether you have questions about our technology, want to collaborate, or just want to learn more, our team is here to help. Reach out and we’ll get back to you as soon as possible.